US 9416360
Base modified oligonucleotides
granted A61PA61P9/00A61P9/10
Quick answer
US patent 9416360 (Base modified oligonucleotides) held by MIRAGEN THERAPEUTICS, INC. expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P9/00, A61P9/10